Clinical trials: Malabsorption
Coeliac Disease, Celiac Disease
Safety Study of Nexvax2 in Subjects With Coeliac Disease
The main purpose of this study is to determine the safety of weekly injections of Nexvax2 given for three weeks to patients with coeliac disease who have been on a gluten-free diet.
- Trial name
- NCT00879749
- Testing
- 9 micrograms Nexvax2, 30 micrograms Nexvax2, 90 micrograms Nexvax2
- Where
- 2 sites in Australia
- Volunteers
- 34 people
- Sponsor
- Nexpep Pty Ltd